article thumbnail

JAK Inhibition May Improve Multiple Autoimmune Conditions in People with Down Syndrome

The Dermatology Digest

More data will be needed to define the safety profile of JAK inhibitors in Down syndrome, and we look forward to the completion of the trial and analysis of the full dataset.”

Clinic 74
article thumbnail

Using CO2 Laser + Other Modalities to Treat Skin Pigmentation

Lipgloss and Aftershave

Research shows that combining treatments improves efficacy, reduces recurrence rates, and minimizes side effects, particularly in addressing conditions like melasma, sunspots, and post-inflammatory hyperpigmentation (Anderson & Anderson, 2020). It can be layered with other actives and light peels for controlled results.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Trending Sources

article thumbnail

Pet Industry and Its Effect on Skincare Market

American Esthetician Organization

According to the American Pet Products Association (APPA), in 2020, Americans spent a staggering $103.6 Additionally, regulatory standards and safety concerns also play a vital role in maintaining trust and credibility within the pet skincare industry. But what exactly drives this growth in the pet industry?

Marketing 164
article thumbnail

Are phthalates something you really need to worry about in cosmetics? No.

The Eco Well Blog

The only phthalate still in use worldwide is diethyl phthalate, which can be used without restriction because of its good safety profile. While there is certainly a concern for some phthalates, particularly with endocrine disruption, the evidence we have to date regarding diethyl phthalate demonstrates safety. Kim, Min Kook, et al.

Safety 52
article thumbnail

Chlormequat: Breakfast Cereals Scrutinized for Pesticide That May Harm Reproduction

Aesthetics Advisor

As this substance infiltrates the American food supply, the potential risks to our health and future generations loom larger, raising urgent questions about the safety of our everyday food choices. Chlormequat is the world’s most common plant growth regulator according to a 2020 study published in Toxicology. Consequently, U.S.

article thumbnail

Cavrotolimod targets PD-1 inhibitor resistance

The Dermatology Digest

As of November 2020, interim results of the phase 1b stage demonstrated a confirmed overall response rate (ORR) of 21%. As of November 2020, progression-free survival exceeded 6 months in all 4 responders, and 16 months in 2 of them. 3 The first patient in the MCC cohort was dosed in June 2020. November 9-14, 2020.

article thumbnail

Cavrotolimod targets PD-1 inhibitor resistance

The Dermatology Digest

As of November 2020, interim results of the phase 1b stage demonstrated a confirmed overall response rate (ORR) of 21%. As of November 2020, progression-free survival exceeded 6 months in all 4 responders, and 16 months in 2 of them. 3 The first patient in the MCC cohort was dosed in June 2020. November 9-14, 2020.